Open Accessibility Menu
Hide

Kelly L. Stratton, MD

  • Accepting New Patients
  • Member of OU Health Physicians

About Kelly Stratton

Kelly L. Stratton, M.D., FACS is an assistant professor of Urologic Oncology in the OU Department of Urology and serves as an Adjunct Assistant Professor of Medical Oncology at the Stephenson Cancer Center. Prior to joining the OU Urology team in 2014, he completed his fellowship training in the Department of Surgery (Urology Service) at Memorial Sloan-Kettering Cancer Center in New York and his residency at Vanderbilt University Medical Center Department of Urology. He completed his MD with special distinction here at the OU College of Medicine in 2007.

Dr. Stratton brings experience with state-of-the-art imaging for the diagnosis and treatment of prostate cancer. He is interested in the application of new technology capable of blending MRI images with real-time ultrasound to improve prostate biopsy and cancer detection. Using these techniques he can assist patients considering prostate cancer treatment options including those who are candidates for active surveillance. He also utilizes genomic testing to help provide personalized treatment plans for patients diagnosed with urologic cancer. Dr. Stratton is the Clinic Director of the Prostate and Urologic Cancer Clinic, he also serves as the Chair of the Stephenson Cancer Center Data Safety Monitoring Board, Disease Site Chair for Urologic Cancers is a member of the Oklahoma TSET Phase I Clinical Trials Program, and is the Director of research of the Department of Urology. Dr. Stratton is involved in several clinical trials that provide the most advanced treatment options currently available.

Dr. Stratton holds memberships in the American Society of Clinical Oncology, the Society of Urologic Oncology and the American Urological Association. He serves as a reviewer for the Journal of Urology and was recently awarded the Best Reviewer in Oncology. He is a contributor to the Practical Reviews in Urology with an emphasis on urologic oncology. Dr. Stratton is also an author of numerous publications and abstracts, as well as of a book chapter for the American Cancer Society regarding inherited predisposition to cancer.

Affiliations OU Health Stephenson Cancer Center, OU Health Stephenson Cancer Center – Prostate & Urologic Cancer, OU Health Physicians – Urology, OU Health Physicians
Health Education
  • College
  • Bachelor of Science University of Oklahoma
    Norman, OK
    2003
  • Medical School
  • College of Medicine University of Oklahoma, College of Medicine
    Oklahoma City, OK
    2007
  • Residency
  • Urology Vanderbilt University Medical Center
    Nashville, TN
    2012
  • Fellowship
  • Urologic Oncology, Chief Administrative Fellow Memorial Sloan-Kettering Cancer Center
    New York, NY
    2014
Medical Interests Areas of Interest:
  • Prostate Cancer
  • Active Surveillance 
  • Prostate MRI and Biopsy
  • Bladder Cancer
  • Kidney Cancer
  • Testicular Cancer
  • Penile Cancer
  • Robotic Surgery
  • Personalized Therapy
Research Interests: Prostate Cancer including advanced imaging with prostate MRI, active surveillance, and nerve sparing robotic prostatectomy
MRI/Ultrasound fusion prostate biopsy using UroNav System
Castration-resistant prostate cancer
Bladder Cancer including bladder preservation and radical cystectomy
Kidney Cancer including cytoreductive nephrectomy, IVC thrombectomy, and robotic-assisted partial nephrectomy
Testicular Cancer including surveillance, nerve-sparing RPLND, and post-chemotherapy RPLND
Penile Cancer including inguinal lymphadenectomy
Star Ratings
Comments